Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ain HoldingsAINPF 82 3-Year EBITDA Growth Rate is 23.30% as of Apr. 2026, which is 94% above its 10-year median of 12.00. GuruFocus rates AINPF with a GF Score™ of 82/100 and a GF Value™ of $49.64. The stock has 2 warning signs investors should review. Among 526 Healthcare Providers & Services companies, Ain Holdings ranks better than 70.34% on this metric.
During the past 12 months, Ain Holdings's average EBITDA Per Share Growth Rate was 54.70% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 23.30% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 17.10% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 5.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Ain Holdings was 23.30% per year. The lowest was -8.20% per year. And the median was 12.00% per year.
Ain Holdings (OTCPK:AINPF) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Ain Holdings 3-Year EBITDA Growth Rate Related Terms
Ain Holdings 3-Year EBITDA Growth Rate Competitor Comparison
For the Pharmaceutical Retailers subindustry, Ain Holdings's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ain Holdings 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ain Holdings's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Ain Holdings's 3-Year EBITDA Growth Rate falls into.
Ain Holdings 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 23.30% mean?
Ain Holdings (AINPF) has a 3-Year EBITDA Growth Rate of 23.30% as of Apr. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Ain Holdings and its competitors. This is 94% above median its historical median of 12.00. According to the industry distribution chart, Ain Holdings ranks #156 out of 526 companies in the Healthcare Providers & Services industry, placing it in the top 29.7%.
Is Ain Holdings' 3-Year EBITDA Growth Rate too high?
Ain Holdings' current 3-Year EBITDA Growth Rate of 23.30% is 94% above median its 10-year median of 12.00. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.05. Ain Holdings' value of 23.30% is 131.8% above this industry median. Based on the distribution chart, Ain Holdings ranks #156 out of 526 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ain Holdings has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Ain Holdings' 3-Year EBITDA Growth Rate compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Ain Holdings ranks #156 out of 526 companies for 3-Year EBITDA Growth Rate. This puts Ain Holdings in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.05. Ain Holdings' value of 23.30% is 131.8% above this benchmark. While the company's 10-year median is 12.00 vs. the industry median of 10.05, Ain Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.05, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ain Holdings's current 3-Year EBITDA Growth Rate of 23.30% is 131.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Ain Holdings and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ain Holdings's current 3-Year EBITDA Growth Rate is 23.30%, which is 94% above median its own 10-year median of 12.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ain Holdings stock overvalued right now?
Ain Holdings (AINPF) has a current 3-Year EBITDA Growth Rate of 23.30%. The stock's GF Value™ is $49.64, compared to a current price of $36.86 — trading 25.7% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 23.30%, which is 94% above median its 10-year median of 12.00 and 131.8% above the Healthcare Providers & Services industry median of 10.05. Ain Holdings' overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Ain Holdings (AINPF), the current 3-Year EBITDA Growth Rate is 23.30% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ain Holdings (AINPF) Overvalued in 2026?
Based on GuruFocus' analysis, Ain Holdings stock appears to be undervalued.
The current stock price of $36.86 is trading 25.7% below its estimated GF Value™ of $49.64.
Key valuation signals for AINPF:
3-Year EBITDA Growth Rate: 23.30% (94% above median its 10-year median of 12.00)
GF Value™: $49.64 vs. price of $36.86 (25.7% below fair value)
Industry Position: 131.8% above the Healthcare Providers & Services median (#156 of 526)
No single metric tells the full story. See the AINPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ain Holdings Inc's core business is the dispensing pharmacy business that includes preparing and dispensing drugs based on prescriptions. The company also generates revenue by selling generic drugs wholesale, pharmacy staffing services, and pharmacy consulting services. The company's additional business activity includes both urban and suburban drug and cosmetic stores. Ain operates the ainz & tuple brand that specifically targets female consumers in urban areas. The company also executes small real estate rental strategies.
82GF Score
Get the complete analysis for AINPF
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AINPF has been successfully added to your 
